Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Vranckx

Showing results (91-100 of 305) with videos related to

Pageof 31
Sort By:
Emergency Medicine Journal : EMJ|April 8, 2022
Mass gathering events: a retrospective analysis of the triage categories, type of injury or medical complaint and medical usage ratesHans Van Remoortel, Hans Scheers, Karen Lauwers, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|December 30, 2008
The TandemHeart, percutaneous transseptal left ventricular assist device: a safeguard in high-risk percutaneous coronary interventions. The six-year Rotterdam experiencePascal Vranckx, Emanuele Meliga, Peter P T De Jaegere, et al.
European Heart Journal|June 1, 2018
Integrating the results of the CULPRIT-SHOCK trial in the 2017 ESC ST-elevation myocardial infarction guidelines: viewpoint of the task forceBorja Ibanez, Sigrun Halvorsen, Marco Roffi, et al.
American Heart Journal|August 2, 2017
Use of endpoint adjudication to improve the quality and validity of endpoint assessment for medical device development and post marketing evaluation: Rationale and best practices. A report from the cardiac safety research consortiumJonathan H Seltzer, Ted Heise, Peter Carson, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|November 9, 2023
Edoxaban and/or colchicine in outpatients with COVID-19: rationale and design of the CONVINCE trialAntonio Landi, Nuccia Morici, Pascal Vranckx, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 7, 2015
Left main or proximal left anterior descending coronary artery disease location identifies high-risk patients deriving potentially greater benefit from prolonged dual antiplatelet therapy durationFrancesco Costa, Marianna Adamo, Sara Ariotti, et al.
American Heart Journal|March 21, 2016
Impact of proton pump inhibitors on clinical outcomes in patients treated with a 6- or 24-month dual-antiplatelet therapy duration: Insights from the PROlonging Dual-antiplatelet treatment after Grading stent-induced Intimal hyperplasia studY trialGiuseppe Gargiulo, Francesco Costa, Sara Ariotti, et al.
Heart (British Cardiac Society)|July 24, 2012
Different cardiac biomarkers to detect peri-procedural myocardial infarction in contemporary coronary stent trials: impact on outcome reportingPascal Vranckx, Vasim Farooq, Scot Garg, et al.
Atherosclerosis|September 12, 2012
Darapladib effect on circulating high sensitive troponin in patients with acute coronary syndromesHéctor M García-García, Rohit M Oemrawsingh, Salvatore Brugaletta, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 20, 2014
How should I treat a cardiac arrest during transcatheter aortic valve implantation?Lionel Leroux, Benjamin Seguy, Louis Labrousse, et al.
Pageof 31

Showing results (91-100 of 305) with videos related to

Sort By:
Pageof 31
Emergency Medicine Journal : EMJ|April 8, 2022
Mass gathering events: a retrospective analysis of the triage categories, type of injury or medical complaint and medical usage ratesHans Van Remoortel, Hans Scheers, Karen Lauwers, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|December 30, 2008
The TandemHeart, percutaneous transseptal left ventricular assist device: a safeguard in high-risk percutaneous coronary interventions. The six-year Rotterdam experiencePascal Vranckx, Emanuele Meliga, Peter P T De Jaegere, et al.
European Heart Journal|June 1, 2018
Integrating the results of the CULPRIT-SHOCK trial in the 2017 ESC ST-elevation myocardial infarction guidelines: viewpoint of the task forceBorja Ibanez, Sigrun Halvorsen, Marco Roffi, et al.
American Heart Journal|August 2, 2017
Use of endpoint adjudication to improve the quality and validity of endpoint assessment for medical device development and post marketing evaluation: Rationale and best practices. A report from the cardiac safety research consortiumJonathan H Seltzer, Ted Heise, Peter Carson, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|November 9, 2023
Edoxaban and/or colchicine in outpatients with COVID-19: rationale and design of the CONVINCE trialAntonio Landi, Nuccia Morici, Pascal Vranckx, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 7, 2015
Left main or proximal left anterior descending coronary artery disease location identifies high-risk patients deriving potentially greater benefit from prolonged dual antiplatelet therapy durationFrancesco Costa, Marianna Adamo, Sara Ariotti, et al.
American Heart Journal|March 21, 2016
Impact of proton pump inhibitors on clinical outcomes in patients treated with a 6- or 24-month dual-antiplatelet therapy duration: Insights from the PROlonging Dual-antiplatelet treatment after Grading stent-induced Intimal hyperplasia studY trialGiuseppe Gargiulo, Francesco Costa, Sara Ariotti, et al.
Heart (British Cardiac Society)|July 24, 2012
Different cardiac biomarkers to detect peri-procedural myocardial infarction in contemporary coronary stent trials: impact on outcome reportingPascal Vranckx, Vasim Farooq, Scot Garg, et al.
Atherosclerosis|September 12, 2012
Darapladib effect on circulating high sensitive troponin in patients with acute coronary syndromesHéctor M García-García, Rohit M Oemrawsingh, Salvatore Brugaletta, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 20, 2014
How should I treat a cardiac arrest during transcatheter aortic valve implantation?Lionel Leroux, Benjamin Seguy, Louis Labrousse, et al.
Pageof 31